Drug Profile
Estradiol/gestodene - Bayer Healthcare Pharmaceuticals
Alternative Names: Avaden; Avaden® 1; Avaden® 2; Convaden; Gestodene/estradiol - Bayer Healthcare PharmaceuticalsLatest Information Update: 05 Feb 2019
Price :
$50
*
At a glance
- Originator Bayer HealthCare Pharmaceuticals
- Class Estradiol congeners; Estrenes; Hormonal replacements; Norpregnenes; Small molecules
- Mechanism of Action Estrogen receptor agonists; Progesterone receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity No
Highest Development Phases
- Marketed Menopausal syndrome; Postmenopausal osteoporosis
Most Recent Events
- 05 Feb 2019 Chemical structure information added
- 01 Mar 2011 Bayer Schering Pharma is now called Bayer Healthcare Pharmaceuticals
- 01 Feb 2008 Withdrawn for Menopausal syndrome in Czech Republic (PO)